Contents of this article
The 11th edition of the International Society of Microbiota world conference on Targeting Microbiota will be held at the Corinthia Palace in Malta from Monday 14th October till Tuesday 15th October 2024.
What is the 11th Targeting Microbiota conference and Why attend?
Targeting Microbiota 2024, under the slogan “Towards Clinical Revolution”, promises to be an innovative event. It will bring together leading experts to discuss the latest advances and future directions in microbiota research and its clinical applications.
To avoid repetitive content, the scientific committee will introduce novel approaches and brand-new research that push the boundaries of current knowledge, ensuring fresh perspectives and innovative solutions.
Two keynote speakers will highlight the potential of microbiota manipulation and the transformative power of the microbiome genome on health:
Phage Therapy: A New Era of an “Old” Concept for “Microbiome” Health – Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia.
The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health – Marvin Edeas, Institut Cochin, INSERM U1016, Université de Paris.
Who will be at the 11th Targeting Microbiota conference?
Key global leaders from across the world will attend.
The congress will bring together directors, department heads, professors, assistant professors, associate professors, research scholars, and scientists from various fields, as well as individuals from start-ups and industries.
Agenda for the 11th Targeting Microbiota 2024
Monday 14th October 2024
Mzia Kutateladze from Eliava Institute of Bacteriophage, Georgia – Phage Therapy: A New Era of “Old” Concept for “Microbiome” Health
Martin Loessner from ETH Zurich, Switzerland – Bacteriophages Redesigned – Tiny Killers and Detectives to Support Infectious Disease Therapy
Alan Walker from University of Aberdeen, United Kingdom – Mythbusting Our Microbiome
Hiroshi Ohno from RIKEN Center for Integrative Medical Sciences, Japan – Gut Microbiome, Obesity & Diabetes: What’s Next
Simone Domenico Guglielmetti from Università degli Studi di Milano-Bicocca, Italy – Gut Microbiome Signatures in Irritable Bowel Syndrome
Patrick C. H. Hsieh from Academia Sinica, Tawian – Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience
Justus Reunanen from University of Oulu, Finland – Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus
Souhaila Al Khodor from Sidra Medicine, Qatar – Deciphering the role of the Oral-Placental and Vaginal-Placental Microbiome Axes in Preterm Birth
Markus Egert from Furtwangen University, Germany – Using Roseoflavin, a Natural Riboflavin Analogue, to Modify the Human Microbiota
Daniela Pacheco CTO and Founder of Bac3Gel, Portugal – Culturing the Complexity of Intestinal Microbiota in vitro in Gut3Gel
Christian Riedel from University of Ulm, Germany – From Microbiomes and (Meta)genomes to the Lab and Back – Identification, Production and Application of Bacteriocins
Tuesday 15th October 2024
Marvin Edeas from Institut Cochin, INSERM U1016, Université de Paris, France – The Mystery of the Microbiome Genome: The Potential of 2 to 20 Million Microbial Genes to Transform Our Health
Carmelo Scarpignato from Chinese University of Hong Kong, China – Drug Effects of Gut Microbiota in Humans: Clinical Consequences
Koen Venema from Maastricht University, Netherlands – Targeting the Microbiota by Medical Professionals: Where are We Now?
Andreas Schwiertz from Institute of Microecology, Germany – Probiotics & Health: How to Select the Right Strain?
Rochellys Diaz Heijtz from Karolinska Institutet, Sweden – Gut Microbiota in Early Life: Impact on Neurodevelopmental Outcomes
José Manuel Fernández-Real from Institut d’Investigació Biomèdica de Girona, University of Girona, Spain – Gut Brain Axis & Depression: Startegic Role of Dietary Proline Exposed
Steven R. Gundry from The Centers for Restorative Medicine, USA – Does the Microbiome Control Cravings and Addictive Behavior of their Host: A New Prospective and Hope for Treating Addiction
Ellen Blaak from Maastricht University, Netherlands – Microbial Phenotypes in Obesity: Implications for Precision Nutrition
Pascale Vonaesch from Department of Fundamental Microbiology, University of Lausanne, Switzerland – Targeting Small Intestinal Microbiota: Impact on Metabolism
Bina Joe from University of Toledo, USA – Prospects for Leveraging the Microbiota as Medicine for Hypertension
Cristian O’Flaherty from McGill University, Canada – Male Fertility and Gut Microbiota: Current Knowledge and Future Directions
View past events by International Society of Microbiota
